Fig. 3From: Real-world outcomes of PD-L1 inhibitors combined with thoracic radiotherapy in the first-line treatment of extensive stage small cell lung cancerForest plot of subgroup analysis of OS. OS, overall survival; TRT, thoracic radiotherapy; ECOG PS, Eastern Cooperative Oncology Group performance status; HR, hazard ratio; CI, confidence intervalBack to article page